ANCN Stock Price, News & Analysis

ANCN NASDAQ

Company Description

ANCN (NASDAQ: ANCN) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

ANCN stock has gained 622.8% over the past year.

This page provides a comprehensive overview of ANCN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+622.84%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

ANCN (ANCN) stock. Over the past 12 months, the stock has gained 622.8%.

Latest News

View All

March 15, 2021

+5.37%

Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing

acquisition

December 15, 2020

+87.01%

Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger Agreement

acquisition

May 11, 2020

-14.03%

Anchiano Therapeutics Reports First Quarter 2020 Financial Results

earnings

May 5, 2020

+5.88%

Anchiano Appoints Steve DiPalma as Chief Financial Officer

management

ANCN has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, earnings, management. View all ANCN news →

SEC Filings

View All

No SEC filings available for ANCN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ANCN Company Profile & Sector Positioning

ANCN (ANCN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.